ID: ALA3326320

Max Phase: Preclinical

Molecular Formula: C16H12ClNO3

Molecular Weight: 301.73

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1cccc(-c2cc(=O)c3cc(Cl)ccc3o2)c1N

Standard InChI:  InChI=1S/C16H12ClNO3/c1-20-14-4-2-3-10(16(14)18)15-8-12(19)11-7-9(17)5-6-13(11)21-15/h2-8H,18H2,1H3

Standard InChI Key:  XRFMEUJKZXAVHQ-UHFFFAOYSA-N

Associated Targets(non-human)

Dual specificity mitogen-activated protein kinase kinase MEK1/2 15 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 301.73Molecular Weight (Monoisotopic): 301.0506AlogP: 3.70#Rotatable Bonds: 2
Polar Surface Area: 65.46Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 3.07CX LogP: 2.58CX LogD: 2.58
Aromatic Rings: 3Heavy Atoms: 21QED Weighted: 0.73Np Likeness Score: 0.13

References

1. Redwan IN, Dyrager C, Solano C, Fernández de Trocóniz G, Voisin L, Bliman D, Meloche S, Grøtli M..  (2014)  Towards the development of chromone-based MEK1/2 modulators.,  85  [PMID:25078316] [10.1016/j.ejmech.2014.07.018]

Source